Atea Pharmaceuticals, Inc. (AVIR)
NGS · Common · CUSIP 04683R106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for AVIR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
04683R106
IPO
10/30/2020 · $24.00/share
Business: Atea Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life-threatening viral diseases.

Company Contact

CEO
Jean-Pierre Sommadossi
CFO
Andrea Corcoran
Headquarters
225 Franklin Street, Suite 2100, Boston, MA 02110
Phone
857-284-8891
Investor Relations
Will O’Connor · 212-362-1200 · will.oconnor@sternir.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »